BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37889870)

  • 21. Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States.
    Jain P; Gutierrez Bugarin J; Guha A; Jain C; Patil N; Shen T; Stanevich I; Nikore V; Margolin K; Ernstoff M; Velcheti V; Barnholtz-Sloan J; Dowlati A
    ESMO Open; 2021 Oct; 6(5):100252. PubMed ID: 34461483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in Use of Next-Generation Sequencing in Patients With Solid Tumors by Race and Ethnicity After Implementation of the Medicare National Coverage Determination.
    Sheinson DM; Wong WB; Meyer CS; Stergiopoulos S; Lofgren KT; Flores C; Adams DV; Fleury ME
    JAMA Netw Open; 2021 Dec; 4(12):e2138219. PubMed ID: 34882180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is Timing of Steroid Exposure Prior to Immune Checkpoint Inhibitor Initiation Associated with Treatment Outcomes in Melanoma? A Population-Based Study.
    Nikita N; Banks J; Keith SW; Song A; Johnson JM; Wilson M; Sharma S; Lu-Yao G
    Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Care at Minority-Serving vs Non-Minority-Serving Hospitals With Use of Palliative Care Among Racial/Ethnic Minorities With Metastatic Cancer in the United States.
    Cole AP; Nguyen DD; Meirkhanov A; Golshan M; Melnitchouk N; Lipsitz SR; Kilbridge KL; Kibel AS; Cooper Z; Weissman J; Trinh QD
    JAMA Netw Open; 2019 Feb; 2(2):e187633. PubMed ID: 30707230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune checkpoint inhibitor use, multimorbidity and healthcare expenditures among older adults with late-stage melanoma.
    Rai P; Shen C; Kolodney J; Kelly KM; Scott VG; Sambamoorthi U
    Immunotherapy; 2021 Feb; 13(2):103-112. PubMed ID: 33148082
    [No Abstract]   [Full Text] [Related]  

  • 26. Racial and Ethnic Disparities in Use of Novel Hormonal Therapy Agents in Patients With Prostate Cancer.
    Ma TM; Agarwal N; Mahal B; Barragan-Carrillo R; Spratt D; Rettig MB; Valle LF; Steinberg ML; Garraway I; Vapiwala N; Xiang M; Kishan AU
    JAMA Netw Open; 2023 Dec; 6(12):e2345906. PubMed ID: 38039002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mediation of Racial and Ethnic Inequities in the Diagnosis of Advanced-Stage Cervical Cancer by Insurance Status.
    Holt HK; Peterson CE; MacLaughlan David S; Abdelaziz A; Sawaya GF; Guadamuz JS; Calip GS
    JAMA Netw Open; 2023 Mar; 6(3):e232985. PubMed ID: 36897588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does Hypothetical Centralization of Revision THA and TKA Exacerbate Existing Geographic or Demographic Disparities in Access to Care by Increased Patient Travel Distances or Times? A Large-database Study.
    Ramirez G; Myers TG; Thirukumaran CP; Ricciardi BF
    Clin Orthop Relat Res; 2022 Jun; 480(6):1033-1045. PubMed ID: 34870619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-Based Disparities in Metastatic Melanoma Patients Treated in the Immune Checkpoint Inhibitors (ICI)
    Safi M; Al-Azab M; Jin C; Trapani D; Baldi S; Adlat S; Wang A; Ahmad B; Al-Madani H; Shan X; Liu J
    Front Immunol; 2021; 12():609728. PubMed ID: 34887846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-World Survival of First-Line Immune Checkpoint Inhibitor Treatment Versus Chemotherapy in Older Patients With Non-Small-Cell Lung Cancer and Synchronous Brain Metastases.
    Mahashabde R; Bhatti SA; Martin BC; Painter JT; Rodriguez A; Ying J; Li C
    JCO Oncol Pract; 2023 Nov; 19(11):1009-1019. PubMed ID: 37729600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disparities in distribution of COVID-19 vaccines across US counties: A geographic information system-based cross-sectional study.
    Hernandez I; Dickson S; Tang S; Gabriel N; Berenbrok LA; Guo J
    PLoS Med; 2022 Jul; 19(7):e1004069. PubMed ID: 35901171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival.
    Sussman TA; Li H; Hobbs B; Funchain P; McCrae KR; Khorana AA
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33436486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Medicare comprehensive medication review on racial/ethnic disparities in nonadherence to statin medications among patients with Alzheimer's Disease: an observational analysis.
    Browning JA; Tsang CCS; Dong X; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Liu C; Wang J
    BMC Health Serv Res; 2022 Feb; 22(1):159. PubMed ID: 35130899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cause-specific mortality by county, race, and ethnicity in the USA, 2000-19: a systematic analysis of health disparities.
    GBD US Health Disparities Collaborators
    Lancet; 2023 Sep; 402(10407):1065-1082. PubMed ID: 37544309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of the American Joint Committee on Cancer Eighth Edition Staging of Patients With Metastatic Cutaneous Melanoma Treated With Immune Checkpoint Inhibitors.
    Waninger JJ; Ma VT; Journey S; Skvarce J; Chopra Z; Tezel A; Bryant AK; Mayo C; Sun Y; Sankar K; Ramnath N; Lao C; Sussman JB; Fecher L; Alva A; Green MD
    JAMA Netw Open; 2021 Mar; 4(3):e210980. PubMed ID: 33687443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.
    Spivey CA; Wang J; Qiao Y; Shih YT; Wan JY; Kuhle J; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    J Manag Care Spec Pharm; 2018 Feb; 24(2):97-107. PubMed ID: 29384031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Racial and Ethnic Disparities in Survival Among People With Second Primary Cancer in the US.
    Sung H; Nisotel L; Sedeta E; Islami F; Jemal A
    JAMA Netw Open; 2023 Aug; 6(8):e2327429. PubMed ID: 37540510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of Immune-related Adverse Events in Melanoma Patients With Preexisting Autoimmune Disease Treated With Immune Checkpoint Inhibitors: A Population-based Study Using SEER-Medicare Data.
    Tully KH; Cone EB; Cole AP; Sun M; Chen X; Marchese M; Roghmann F; Kilbridge KL; Trinh QD
    Am J Clin Oncol; 2021 Aug; 44(8):413-418. PubMed ID: 34081033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telehealth Usage Among Low-Income Racial and Ethnic Minority Populations During the COVID-19 Pandemic: Retrospective Observational Study.
    Williams C; Shang D
    J Med Internet Res; 2023 May; 25():e43604. PubMed ID: 37171848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Race and Ethnicity and Medicare Program Type With Ambulatory Care Access and Quality Measures.
    Johnston KJ; Hammond G; Meyers DJ; Joynt Maddox KE
    JAMA; 2021 Aug; 326(7):628-636. PubMed ID: 34402828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.